The global interventional cardiology devices market, valued at US$26.32 billion in 2023, is forecasted to grow at a robust ...

Oppenheimer predicts growth for Penumbra Inc in MT market. Analyst initiates coverage with Outperform rating and $275 target ...

Techniques for thrombus removal include catheter-directed thrombolysis, mechanical thrombectomy and various combinations of both (pharmacomechanical catheter-directed thrombolysis). There are no ...

Medikit is a market leader in Japan in interventional products, including vascular access devices such as hemodialysis catheters ... Following Mechanical Thrombectomy for Deep Vein Thrombosis ...

Oppenheimer initiated coverage of Penumbra (PEN) with an Outperform rating and $275 price target Penumbra is a leader in the mechanical ...

Objective: Following the introduction and widespread use of central venous catheters (CVCs) in adults, these devices are being used with increasing frequency in the pediatric population.

Specific catheter selection within each arm, as well as thrombectomy techniques, were left to the treatment team’s discretion. The trial was terminated early for safety following an interim analysis ...

Quantinno Capital Management LP bought a new stake in shares of Penumbra, Inc. (NYSE ... a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.